Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation.
Manickam AshokkumarWenwen MeiJackson J PetersonYuriko HarigayaDavid M MurdochDavid M MargolisCaleb KornfeinAlex OesterlingZhicheng GuoCynthia D RudinYuchao JiangEdward P BrownePublished in: Genomics, proteomics & bioinformatics (2024)
Despite the success of antiretroviral therapy, human immunodeficiency virus (HIV) cannot be cured because of a reservoir of latently infected cells that evades therapy. To understand the mechanisms of HIV latency, we employed an integrated single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) approach to simultaneously profile the transcriptomic and epigenomic characteristics of ∼ 125,000 latently infected primary CD4+ T cells after reactivation using three different latency reversing agents. Differentially expressed genes and differentially accessible motifs were used to examine transcriptional pathways and transcription factor (TF) activities across the cell population. We identified cellular transcripts and TFs whose expression/activity was correlated with viral reactivation and demonstrated that a machine learning model trained on these data was 75%-79% accurate at predicting viral reactivation. Finally, we validated the role of two candidate HIV-regulating factors, FOXP1 and GATA3, in viral transcription. These data demonstrate the power of integrated multimodal single-cell analysis to uncover novel relationships between host cell factors and HIV latency.
Keyphrases
- single cell
- antiretroviral therapy
- human immunodeficiency virus
- rna seq
- hiv infected
- hiv positive
- transcription factor
- hiv aids
- high throughput
- hiv infected patients
- hepatitis c virus
- hiv testing
- sars cov
- machine learning
- gene expression
- electronic health record
- men who have sex with men
- oxidative stress
- pain management
- regulatory t cells
- poor prognosis
- stem cells
- dna damage
- cell death
- cell therapy
- deep learning
- replacement therapy
- high resolution
- data analysis
- heat shock protein
- genome wide identification